DOI QR코드

DOI QR Code

Delphinidin inhibits cell proliferation and induces apoptosis in MDA-MB-231 human breast cancer cell lines

Delphinidin이 인체 유방암세포 MDA-MB-231의세포증식 억제와 세포사멸 유도에 미치는 영향

  • Seo, Eun Young (Department of Food and Nutrition, Jangan University)
  • 서은영 (장안대학교 식품영양과)
  • Received : 2013.11.14
  • Accepted : 2013.12.03
  • Published : 2013.12.31

Abstract

Breast cancer is the most common malignancy in women, both in the developed and developing countries. Anthocyanins are natural coloring of a multitude of foods, such as berries, grapes or cherries. Glycosides of the aglycons delphinidin represent the most abundant anthocyanins in fruits. Delphinidin has recently been reported to inhibit the growth of human tumor cell line. Also, delphinidin is a powerful antioxidant that reportedly exerts beneficial effects in patients with advanced cancer by reducing the level of reactive oxygen species and increasing glutathion peroxidase activity. This study investigates the effects of delphinidin on protein ErbB2, ErbB3 and Akt expressions associated with cell proliferation and Bcl-2, Bax protein associated with cell apoptosis in MDA-MB-231 human breast cancer cell line. MDA-MB-231 cells were cultured with various concentrations (0, 5, 10, and $20{\mu}mol/L$) of delphinidin. Delphinidin inhibited breast cancer cell growth in a dose dependent manner (p < 0.05). ErbB2 and ErbB3 expressions were markdly lower $5{\mu}mol/L$ delphinidin (p < 0.05). In addition, total Akt and phosphorylated Akt levels were decreased dose-dependently in cells treated with delphinidin (p < 0.05). Futher, Bcl-2 levels were dose-dependently decreased and Bax expression was significantly increased in cells treated with delphinidin (p < 0.05). In conclusion, I have shown that delphinidin inhibits cell growth, proliferation and induces apoptosis in MDA-MB-231 human breast cancer cell lines.

References

  1. National Health Insurance Service (KR). Analysis of cancer patients in 2008 [Internet]. Seoul: National Health Insurance Service; 2010 [cited 2010 Jun 5]. Available from: http://www.nhis. or.kr/cms/board/board/Board.jsp?act=VIEW&communityKey= B0070&boardId=20108
  2. National Cancer Information Center (KR). Types of breast cancer [Internet]. Goyang: National Cancer Information Center; 2013 [cited 2013 February 1]. Available from: http://www.cancer.go.kr/mbs/ cancer/jsp/cancer/cancer.jsp?cancerSeq=4757&menuSeq=4761 &viewType=all&id=cancer_020112000000
  3. Korean Breast Cancer Society. Breast cancer facts & figures 2006- 2008. Seoul: Korean Breast Cancer Society; 2008
  4. Doll R, Peto R. The causes of cancer: quantitative estimates of avoi dable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66(6): 1191-1308
  5. Wu C, Ray RM, Lin MG, Gao DL, Horner NK, Nelson ZC, Lampe JW, Hu YW, Shannon J, Stalsberg H, Li W, Fitzgibbons D, Porter P, Patterson RE, Satia JA, Thomas DB. A case-control study of risk factors for fibrocystic breast conditions: Shanghai Nutrition and Breast Disease Study, China, 1995-2000. Am J Epidemiol 2004; 160(10): 945-960 https://doi.org/10.1093/aje/kwh318
  6. Magee PJ, McGlynn H, Rowland IR. Differential effects of isoflavones and lignans on invasiveness of MDA-MB-231 breast cancer cells in vitro. Cancer Lett 2004; 208(1): 35-41 https://doi.org/10.1016/j.canlet.2003.11.012
  7. Schley PD, Jijon HB, Robinson LE, Field CJ. Mechanisms of omega- 3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat 2005; 92(2): 187-195 https://doi.org/10.1007/s10549-005-2415-z
  8. Klass CM, Shin DM. Current status and future perspectives of chemoprevention in head and neck cancer. Curr Cancer Drug Targets 2007; 7(7): 623-632 https://doi.org/10.2174/156800907782418347
  9. Lila MA. From beans to berries and beyond: teamwork between plant chemicals for protection of optimal human health. Ann N Y Acad Sci 2007; 1114: 372-380 https://doi.org/10.1196/annals.1396.047
  10. Harborne JB. Comparative biochemistry of the flavonoids. New York (NY): Academic Press; 1967
  11. Bae EA, Moon GS. A study on the antioxidative activities of Korean soybeans. J Korean Soc Food Sci Nutr 1997; 26(2): 203-208
  12. Ding M, Feng R, Wang SY, Bowman L, Lu Y, Qian Y, Castranova V, Jiang BH, Shi X. Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity. J Biol Chem 2006; 281(25): 17359-17368 https://doi.org/10.1074/jbc.M600861200
  13. Hou DX. Potential mechanisms of cancer chemoprevention by anthocyanins. Curr Mol Med 2003; 3(2): 149-159 https://doi.org/10.2174/1566524033361555
  14. Katsube N, Iwashita K, Tsushida T, Yamaki K, Kobori M. Induction of apoptosis in cancer cells by Bilberry (Vaccinium myrtillus) and the anthocyanins. J Agric Food Chem 2003; 51(1): 68-75 https://doi.org/10.1021/jf025781x
  15. Yoon TH, Lee SW. Stability of anthocyanins in foods. Korean J Food Sci Technol 1979; 11(1): 63-73
  16. Kong JM, Chia LS, Goh NK, Chia TF, Brouillard R. Analysis and biological activities of anthocyanins. Phytochemistry 2003; 64 (5): 923-933 https://doi.org/10.1016/S0031-9422(03)00438-2
  17. Chu SK, Seo EY, Kim WK, Kang NE. Effect of cyanidin on cell motility and invasion in MDA-MB-231 human breast cancer cells. Korean J Nutr 2008; 41(8): 711-717
  18. Li L, Adams LS, Chen S, Killian C, Ahmed A, Seeram NP. Eugenia jambolana Lam. Berry extract inhibits growth and induces apoptosis of human breast cancer but not non-tumorigenic breast cells. J Agric Food Chem 2009; 57(3): 826-831 https://doi.org/10.1021/jf803407q
  19. Hui C, Bin Y, Xiaoping Y, Long Y, Chunye C, Mantian M, Wenhua L. Anticancer activities of an anthocyanin-rich extract from black rice against breast cancer cells in vitro and in vivo. Nutr Cancer 2010; 62(8): 1128-1136 https://doi.org/10.1080/01635581.2010.494821
  20. Weng MS, Ho CT, Ho YS, Lin JK. Theanaphthoquinone inhibits fatty acid synthase expression in EGF-stimulated human breast cancer cells via the regulation of EGFR/ErbB-2 signaling. Toxicol Appl Pharmacol 2007; 218(2): 107-118 https://doi.org/10.1016/j.taap.2006.10.021
  21. Seo EY, Lee HS, Kim WK. Effect of [6]-gingerol on inhibition of cell proliferation in MDA-MB-231 human breast cancer cells. Korean J Nutr 2005; 38(8): 656-662
  22. Landesberg R, Cozin M, Cremers S, Woo V, Kousteni S, Sinha S, Garrett-Sinha L, Raghavan S. Inhibition of oral mucosal cell wound healing by bisphosphonates. J Oral Maxillofac Surg 2008; 66(5): 839-847 https://doi.org/10.1016/j.joms.2008.01.026
  23. Meiers S, Kemény M, Weyand U, Gastpar R, von Angerer E, Marko D. The anthocyanidins cyanidin and delphinidin are potent inhibitors of the epidermal growth-factor receptor. J Agric Food Chem 2001; 49(2): 958-962 https://doi.org/10.1021/jf0009100
  24. Zhang Y, Vareed SK, Nair MG. Human tumor cell growth inhibition by nontoxic anthocyanidins, the pigments in fruits and vegetables. Life Sci 2005; 76(13): 1465-1472 https://doi.org/10.1016/j.lfs.2004.08.025
  25. Martin S, Andriambeloson E, Takeda K, Andriantsitohaina R. Red wine polyphenols increase calcium in bovine aortic endothelial cells: a basis to elucidate signalling pathways leading to nitric oxide production. Br J Pharmacol 2002; 135(6): 1579-1587 https://doi.org/10.1038/sj.bjp.0704603
  26. Koide T, Hashimoto Y, Kamei H, Kojima T, Hasegawa M, Terabe K. Antitumor effect of anthocyanin fractions extracted from red soybeans and red beans in vitro and in vivo. Cancer Biother Radiopharm 1997; 12(4): 277-280
  27. Marko D, Puppel N, Tjaden Z, Jakobs S, Pahlke G. The substitution pattern of anthocyanidins affects different cellular signaling cascades regulating cell proliferation. Mol Nutr Food Res 2004; 48(4): 318-325 https://doi.org/10.1002/mnfr.200400034
  28. Sainsbury JR, Malcolm AJ, Appleton DR, Farndon JR, Harris AL. Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol 1985; 38(11): 1225-1228 https://doi.org/10.1136/jcp.38.11.1225
  29. Sainsbury JR, Farndon JR, Needham GK, Malcolm AJ, Harris AL. Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet 1987; 1(8547): 1398-1402
  30. Koenders PG, Beex LV, Geurts-Moespot A, Heuvel JJ, Kienhuis CB, Benraad TJ. Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor- positive human primary breast cancers. Cancer Res 1991; 51(17): 4544-4548
  31. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235(4785): 177-182 https://doi.org/10.1126/science.3798106
  32. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989; 244(4905): 707-712 https://doi.org/10.1126/science.2470152
  33. Toi M, Osaki A, Yamada H, Toge T. Epidermal growth factor receptor expression as a prognostic indicator in breast cancer. Eur J Cancer 1991; 27(8): 977-980 https://doi.org/10.1016/0277-5379(91)90262-C
  34. De Potter CR, Beghin C, Makar AP, Vandekerckhove D, Roels HJ. The neu-oncogene protein as a predictive factor for haematogenous metastases in breast cancer patients. Int J Cancer 1990; 45(1): 55-58 https://doi.org/10.1002/ijc.2910450112
  35. Gusterson BA, Machin LG, Gullick WJ, Gibbs NM, Powles TJ, Elliott C, Ashley S, Monaghan P, Harrison S. c-erbB-2 expression in benign and malignant breast disease. Br J Cancer 1988; 58(4): 453-457 https://doi.org/10.1038/bjc.1988.239
  36. Sweeney C, Fambrough D, Huard C, Diamonti AJ, Lander ES, Cantley LC, Carraway KL 3rd. Growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors. J Biol Chem 2001; 276(25): 22685-22698 https://doi.org/10.1074/jbc.M100602200
  37. Crovello CS, Lai C, Cantley LC, Carraway KL 3rd. Differential signaling by the epidermal growth factor-like growth factors neuregulin- 1 and neuregulin-2. J Biol Chem 1998; 273(41): 26954- 26961 https://doi.org/10.1074/jbc.273.41.26954
  38. Tzahar E, Pinkas-Kramarski R, Moyer JD, Klapper LN, Alroy I, Levkowitz G, Shelly M, Henis S, Eisenstein M, Ratzkin BJ, Sela M, Andrews GC, Yarden Y. Bivalence of EGF-like ligands drives the ErbB signaling network. EMBO J 1997; 16(16): 4938-4950 https://doi.org/10.1093/emboj/16.16.4938
  39. Graus-Porta D, Beerli RR, Daly JM, Hynes NE. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J 1997; 16(7): 1647-1655 https://doi.org/10.1093/emboj/16.7.1647
  40. Franke TF, Kaplan DR, Cantley LC. PI3K: downstream AKTion blocks apoptosis. Cell 1997; 88(4): 435-437 https://doi.org/10.1016/S0092-8674(00)81883-8
  41. Meyskens FL Jr, Szabo E. Diet and cancer: the disconnect between epidemiology and randomized clinical trials. Cancer Epidemiol Biomarkers Prev 2005; 14(6): 1366-1369 https://doi.org/10.1158/1055-9965.EPI-04-0666
  42. Ramos S, Alía M, Bravo L, Goya L. Comparative effects of foodderived polyphenols on the viability and apoptosis of a human hepatoma cell line (HepG2). J Agric Food Chem 2005; 53(4): 1271- 1280 https://doi.org/10.1021/jf0490798
  43. Heo HJ, Lee CY. Strawberry and its anthocyanins reduce oxidative stress-induced apoptosis in PC12 cells. J Agric Food Chem 2005; 53(6): 1984-1989 https://doi.org/10.1021/jf048616l
  44. Tessitore L, Davit A, Sarotto I, Caderni G. Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis 2000; 21(8): 1619-1622 https://doi.org/10.1093/carcin/21.8.1619
  45. Bunz F, Hwang PM, Torrance C, Waldman T, Zhang Y, Dillehay L, Williams J, Lengauer C, Kinzler KW, Vogelstein B. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Invest 1999; 104(3): 263-269 https://doi.org/10.1172/JCI6863
  46. Afaq F, Syed DN, Malik A, Hadi N, Sarfaraz S, Kweon MH, Khan N, Zaid MA, Mukhtar H. Delphinidin, an anthocyanidin in pigmented fruits and vegetables, protects human HaCaT keratinocytes and mouse skin against UVB-mediated oxidative stress and apoptosis. J Invest Dermatol 2007; 127(1): 222-232 https://doi.org/10.1038/sj.jid.5700510
  47. Lazzè MC, Savio M, Pizzala R, Cazzalini O, Perucca P, Scovassi AI, Stivala LA, Bianchi L. Anthocyanins induce cell cycle perturbations and apoptosis in different human cell lines. Carcinogenesis 2004; 25(8): 1427-1433 https://doi.org/10.1093/carcin/bgh138
  48. Shih PH, Yeh CT, Yen GC. Effects of anthocyanidin on the inhibition of proliferation and induction of apoptosis in human gastric adenocarcinoma cells. Food Chem Toxicol 2005; 43(10): 1557-1566 https://doi.org/10.1016/j.fct.2005.05.001

Cited by

  1. Radioprotective effects of delphinidin on normal human lung cells against proton beam exposure vol.12, pp.1, 2018, https://doi.org/10.4162/nrp.2018.12.1.41